| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.48 | $43.20 (0%) | 🛒 Add to cart |
| 120 | $0.45 | $57.60 $54.25 (6%) | 🛒 Add to cart |
| 180 | $0.43 | $86.41 $77.36 (10%) | 🛒 Add to cart |
| 270 | $0.41 | $129.61 $111.52 (14%) | 🛒 Add to cart |
| 360 | $0.40
Best per pill | $172.81 $144.68 (16%) | 🛒 Add to cart |
Similar products
More info:
Pariet: Potent Acid Control for GERD and Ulcer Healing - Evidence-Based Review
Pariet is a proton pump inhibitor (PPI) containing the active ingredient rabeprazole sodium. It’s available in delayed-release tablet form, typically 20mg, designed for once-daily administration. As a second-generation PPI, it offers more rapid and predictable acid suppression than earlier agents. 1. Introduction: What is Pariet? Its Role in Modern Medicine Pariet represents the evolution of acid-suppression therapy, bridging the gap between first-generation PPIs and contemporary treatment needs. What is Pariet used for?
Aciphex: Potent Acid Suppression for GERD and Ulcer Healing - Evidence-Based Review
Aciphex, known generically as rabeprazole sodium, represents a significant advancement in proton pump inhibitor (PPI) therapy for acid-related gastrointestinal disorders. As a delayed-release tablet, it works by selectively and irreversibly blocking the H+/K+ ATPase enzyme system—the “acid pump”—at the secretory surface of gastric parietal cells. This mechanism provides potent, prolonged suppression of gastric acid secretion, making it a cornerstone in managing conditions like GERD, erosive esophagitis, and Zollinger-Ellison syndrome. Unlike earlier PPIs, Aciphex demonstrates more rapid onset of acid control and maintains consistent pH elevation with once-daily dosing, though individual metabolic variations (particularly CYP2C19 polymorphism) can influence its efficacy.
modaheal
Modaheal is a novel medical-grade cognitive enhancement device that’s been generating significant discussion in our neurology department lately. It’s not another nootropic supplement or pharmaceutical intervention, but rather a non-invasive neuromodulation system that uses precisely calibrated transcranial direct current stimulation (tDCS) to enhance working memory and executive function. We’ve been running a small clinical trial with it for about eight months now, and the results have been… well, let’s just say they’ve surprised even our most skeptical team members.
nexium
Nexium, known generically as esomeprazole, represents the purified (S)-isomer of omeprazole and belongs to the proton pump inhibitor (PPI) class of medications. It functions by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell, leading to potent and prolonged suppression of gastric acid secretion. This mechanism provides superior acid control compared to earlier antisecretory agents like H2-receptor antagonists, fundamentally changing the management landscape for acid-related disorders.
Pepcid: Effective Acid Reduction for GERD and Ulcer Management - Evidence-Based Review
Pepcid, known generically as famotidine, is a histamine-2 (H2) receptor antagonist that has been a cornerstone in managing gastric acid-related disorders for decades. Initially approved by the FDA in the 1980s, it works by selectively inhibiting histamine at the H2 receptors of gastric parietal cells, leading to a significant reduction in both the volume and concentration of gastric acid. This mechanism provides symptomatic relief and promotes healing in conditions like gastroesophageal reflux disease (GERD) and peptic ulcers.
prevacid
Let me walk you through our experience with Prevacid over the years - I’ve been prescribing proton pump inhibitors since they first hit the market in the 90s, and this one’s been particularly interesting to follow. Prevacid contains lansoprazole as its active ingredient, which belongs to the proton pump inhibitor class of medications. What’s fascinating about lansoprazole is how it specifically targets the gastric proton pump - that H+/K+ ATPase enzyme system in the parietal cells.
Prilosec: Effective Acid Reduction for GERD and Ulcers - Evidence-Based Review
Prilosec, known generically as omeprazole, is a proton pump inhibitor (PPI) available both as a prescription medication and over-the-counter. It’s fundamentally used to reduce stomach acid production, providing relief and healing for various acid-related gastrointestinal conditions. Its mechanism involves irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system—the “acid pump”—in the gastric parietal cells. This action makes it a cornerstone in managing GERD, erosive esophagitis, and Zollinger-Ellison syndrome, among others. The development of omeprazole in the late 1980s marked a significant advancement over H2-receptor antagonists, offering more potent and prolonged acid suppression.
Protonix: Potent and Prolonged Gastric Acid Suppression for GERD and Ulcer Healing - Evidence-Based Review
Protonix, known generically as pantoprazole, is a proton pump inhibitor (PPI) prescribed for managing gastric acid-related disorders. It works by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system (the proton pump) of the gastric parietal cell, leading to profound and prolonged suppression of gastric acid secretion. Available in both oral and intravenous formulations, it’s a cornerstone therapy for conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. Its delayed-release tablets ensure the active ingredient survives the acidic stomach environment to be absorbed in the small intestine.
Ranitidine: Effective Acid Reduction Therapy - Evidence-Based Review
Ranitidine hydrochloride is a histamine H2-receptor antagonist that revolutionized gastrointestinal medicine when it first appeared in the 1980s. As a senior gastroenterologist who’s prescribed this medication for over three decades, I’ve witnessed its entire lifecycle from breakthrough therapy to market withdrawal. The molecule works by competitively inhibiting histamine at H2 receptors of gastric parietal cells, effectively reducing basal and nocturnal gastric acid secretion. What made ranitidine particularly valuable was its favorable side effect profile compared to earlier H2 antagonists and its reliable efficacy across various acid-related conditions.